For: | Tanaka T, Fujimura A, Ichimura K, Yanai H, Sato Y, Takata K, Okada H, Kawano S, Tanabe S, Yoshino T. Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma. World J Gastroenterol 2012; 18(43): 6263-6268 [PMID: 23180947 DOI: 10.3748/wjg.v18.i43.6263] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i43/6263.htm |
Number | Citing Articles |
1 |
Khaldoun Almhanna, Marilin Rosa, Evita Henderson-Jackson, Kun Jiang, Rania Shamekh, Zena Sayegh, Mokenge P. Malafa, Domenico Coppola. Her-2 Expression in Gastroesophageal Intestinal Metaplasia, Dysplasia, and Adenocarcinoma. Applied Immunohistochemistry & Molecular Morphology 2016; 24(9): 633 doi: 10.1097/PAI.0000000000000243
|
2 |
Mahboubeh S. Noori, Sarah J. Bodle, Christian A. Showalter, Evan S. Streator, David S. Drozek, Monica M. Burdick, Douglas J. Goetz. Sticking to the Problem: Engineering Adhesion in Molecular Endoscopic Imaging. Cellular and Molecular Bioengineering 2020; 13(2): 113 doi: 10.1007/s12195-020-00609-0
|
3 |
Aaron R Huber, Brandon Buscaglia, Brooke R Koltz, Jill Henry, Loralee McMahon, James Guo, David G Hicks, Christa L Whitney-Miller. Impact of Specimen Type and Specimen Number on HER2 Status in Gastroesophageal Junction and Gastric Adenocarcinoma. American Journal of Clinical Pathology 2019; 151(5): 461 doi: 10.1093/ajcp/aqy166
|
4 |
Antonio Ieni, Roberta Cardia, Cristina Pizzimenti, Pio Zeppa, Giovanni Tuccari. HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different Methodologies. Journal of Personalized Medicine 2020; 10(1): 10 doi: 10.3390/jpm10010010
|